What would the FDA do to expedite drug development and approval for an outbreak of smallpox, for which there is no known treatment?
a. List smallpox as a health orphan disease.
b. Omit the preclinical research phase.
c. Extend the clinical research phase.
d. Fast track the investigational drug.
ANS: D
Once the Investigational New Drug Application has been approved, the drug can receive highest priority within the agency, which is called fast tracking. A smallpox outbreak would become a priority concern in the world. Orphan diseases are not researched in a priority manner. Preclinical research is not omitted. Extending any phase of the research would mean a longer time to develop a vaccine. The FDA must ensure that all phases of the preclinical and clinical research phase have been completed in a safe manner.
You might also like to view...
A client received 5.4 liters of IV fluid during a surgical procedure. How many mL of IV fluid did the client receive? _____ mL
ANS:
A client with diabetes and coronary artery disease asks health care staff and family what they think
she should do each time a decision is to be made. She often fails to follow therapeutic advice after seeking professional opinions. On the basis of this information, the information that would be found on axis III of the DSM-IV-TR would be a. diabetes and coronary artery disease. b. dependent personality. c. maladaptive health behaviors: high-fat diet, lack of exercise. d. persistent failure to follow professional advice of health care staff.
What is the systematic application of information and computer science and technology to public health practice, research, and learning?
1. Public health nursing 2. Public health practice 3. Public health informatics 4. Public health research
After implementing health promotion activities and plans to prioritize health problems, the community must evaluate the effectiveness of the interventions. Which groups would be involved in this process?
A) Hospital and clinic personnel who administered health care needs B) Those consumers who were directly affected by the services provided C) Health care providers, consumers, community leaders, and politicians D) Health care providers at the community level